nsp12-IN-1
Nsp12-IN-1 is a nucleoside analogue. Nsp12-IN-1 can block the synthesis of viral RNA and inhibit viral replication. Nsp12-IN-1 can be used in the study of pan-coronavirus.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C13H16FN5O5
- Molecular Weight:341.30
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Nsp12-IN-1 is a nucleoside analogue. Nsp12-IN-1 can block the synthesis of viral RNA and inhibit viral replication. Nsp12-IN-1 can be used in the study of pan-coronavirus[1].
In Vitro
In Vivo
Nsp12-IN-1 (2 mg/kg, i.v.; 30mg/kg p.o.; 24h) improves oral bioavailability, but the absolute bioavailability of these compounds remains low in female Balb-c mice[1].
Pharmacokinetic Analysis in female Balb-c mice[1]
Pharmacokinetic Analysis in female Balb-c mice[1]
| Dosed compound | Route | Dose (mg/kg) | AUC |
T1/2 (h) | Tmax (h) | Cmax (ng/mL) | F (%) |
| 10n | i.v. | 2 | 118 | 1.2 | 0.50 | 55 | / |
| 10n | p.o. | 30 | 171 | 4.3 | 2.0 | 49 | 9.6 |
| 12a | p.o. | 30 | 504 | 1.5 | 1.0 | 190 | 28.4 |
| 12b | p.o. | 30 | 847 | 3.4 | 0.67 | 301 | 47.7 |